Endocrinology and Metabolism

Brief Report

Adrenal Gland
Urinary Free Metanephrines for Diagnosis of Pheochromocytoma and Paraganglioma: Jiyeon Ahn, Ji Yun Park, Gyuri Kim, Sang-Man Jin, Kyu Yeon Hur, Soo-Youn Lee, Jae Hyeon Kim; Endocrinol Metab. 2021;36(3):697-701. Published online June 1, 2021; DOI: https://doi.org/10.3803/EnM.2020.925

4,390 View
188 Download
2 Web of Science
2 Crossref

Abstract PDF Supplementary Material PubReader ePub

Background
Pheochromocytoma and paraganglioma (PPGL) is diagnosed through biochemical confirmation of excessive catecholamines in urine and plasma. Recent technological developments have allowed us to measure urinary free metanephrines; however, the diagnostic accuracy of these new methods and the diagnostic cutoff values have not been evaluated.
Methods
This is a retrospective study of 595 subjects, including 71 PPGL cases and 524 controls. PPGL was based on pathological confirmation. Subjects with no evidence of PPGL over 2 years were included in the control group.
Results
Urinary free metanephrines yielded similar area under the curve (AUC) to urinary fractionated metanephrines and plasma free metanephrines. However, urinary free normetanephrine yielded a better AUC than did urinary fractionated normetanephrine. The optimal cutoff for urinary free metanephrine and normetanephrine corrected for urinary creatinine yielded 97.2% sensitivity and 98.1% specificity.
Conclusion
Urinary free metanephrines are a reliable method for diagnosing PPGL in Asian populations compared with existing biochemical methods.

Citations

Citations to this article as recorded by

Biochemical Assessment of Pheochromocytoma and Paraganglioma
Graeme Eisenhofer, Christina Pamporaki, Jacques W M Lenders
Endocrine Reviews.2023; 44(5): 862. CrossRef
Adrenal bleeding due to pheochromocytoma - A call for algorithm
Ewelina Rzepka, Joanna Kokoszka, Anna Grochowska, Magdalena Ulatowska-Białas, Martyna Lech, Marta Opalińska, Elwira Przybylik-Mazurek, Aleksandra Gilis-Januszewska, Alicja Hubalewska-Dydejczyk
Frontiers in Endocrinology.2022;[Epub] CrossRef

Original Article

Clinical Study
A 5-Year Prospective Follow-Up Study of Lipid-Rich Adrenal Incidentalomas: No Tumor Growth or Development of Hormonal Hypersecretion: Camilla Schalin-Jäntti, Merja Raade, Esa Hämäläinen, Timo Sane; Endocrinol Metab. 2015;30(4):481-487. Published online December 31, 2015; DOI: https://doi.org/10.3803/EnM.2015.30.4.481

3,594 View
45 Download
22 Web of Science
22 Crossref

Abstract PDF PubReader

Background

Current guidelines for follow-up of adrenal incidentalomas are extensive and hampered by lack of follow-up studies. We tested the hypothesis that small lipid-rich adrenal incidentalomas, initially characterized by tumor size <40 mm and <10 Hounsfield units (HUs) on unenhanced computed tomography (CT) may not demonstrate excessive growth/hormonal hypersecretion on follow-up.

Methods

Sixty-nine incidentalomas in 56 patients were restudied with unenhanced CT and screening for hypercortisolism (dexamethasone suppression test [DST], plasma adrenocorticotropic hormone) and pheochromocytoma (24-hour urinary metanephrines and normetanephrines) 5 years later. Primary hyperaldosteronism was excluded at base-line.

Results

Tumor (n=69) size was similar before and after 5 years follow-up (19±6 mm vs. 20±7 mm). Mean tumor growth was 1±2 mm. Largest increase in tumor size was 8 mm, this tumor was surgically removed and histopathology confirmed cortical adenoma. DST was normal in 54 patients and two patients (3.6%) were still characterized by subclinical hypercortisolism. Initial tumor size was >20 mm for the patient with largest tumor growth and those with subclinical hypercortisolism. All patients had normal 24-hour urinary metanephrines and normetanephrines. Low attenuation (<10 HU) was demonstrated in 97% of 67 masses re-evaluated with unenhanced CT.

Conclusion

None of the patients developed clinically relevant tumor growth or new subclinical hypercortisolism. Biochemical screening for pheochromocytoma in incidentalomas demonstrating <10 HU on unenhanced CT is not needed. For such incidentalomas <40 mm, it seems sufficient to perform control CT and screen for hypercortisolism after 5 years.

Citations

Citations to this article as recorded by

European Society of Endocrinology clinical practice guidelines on the management of adrenal incidentalomas, in collaboration with the European Network for the Study of Adrenal Tumors
Martin Fassnacht, Stylianos Tsagarakis, Massimo Terzolo, Antoine Tabarin, Anju Sahdev, John Newell-Price, Iris Pelsma, Ljiljana Marina, Kerstin Lorenz, Irina Bancos, Wiebke Arlt, Olaf M Dekkers
European Journal of Endocrinology.2023; 189(1): G1. CrossRef
Diagnostic Accuracy of CT Texture Analysis in Adrenal Masses: A Systematic Review
Filippo Crimì, Emilio Quaia, Giulio Cabrelle, Chiara Zanon, Alessia Pepe, Daniela Regazzo, Irene Tizianel, Carla Scaroni, Filippo Ceccato
International Journal of Molecular Sciences.2022; 23(2): 637. CrossRef
Susceptibility and characteristics of infections in patients with glucocorticoid excess or insufficiency: the ICARO tool
Marianna Minnetti, Valeria Hasenmajer, Emilia Sbardella, Francesco Angelini, Chiara Simeoli, Nicola Di Paola, Alessia Cozzolino, Claudia Pivonello, Dario De Alcubierre, Sabrina Chiloiro, Roberto Baldelli, Laura De Marinis, Rosario Pivonello, Riccardo Pofi
European Journal of Endocrinology.2022; 187(5): 719. CrossRef
Approach to large adrenal tumors
Urszula Ambroziak
Current Opinion in Endocrinology, Diabetes & Obesity.2021; 28(3): 271. CrossRef
Frequently asked questions and answers (if any) in patients with adrenal incidentaloma
F. Ceccato, M. Barbot, C. Scaroni, M. Boscaro
Journal of Endocrinological Investigation.2021; 44(12): 2749. CrossRef
Draft of the clinical practice guidelines “Adrenal incidentaloma”
D. G. Beltsevich, E. A. Troshina, G. A. Melnichenko, N. M. Platonova, D. O. Ladygina, A. Chevais
Endocrine Surgery.2021; 15(1): 4. CrossRef
Attenuation Value in Adrenal Incidentalomas: A Longitudinal Study
Filippo Ceccato, Irene Tizianel, Giacomo Voltan, Gianmarco Maggetto, Isabella Merante Boschin, Emilio Quaia, Filippo Crimì, Carla Scaroni
Frontiers in Endocrinology.2021;[Epub] CrossRef
Guía práctica sobre la evaluación inicial, seguimiento y tratamiento de los incidentalomas adrenales. Grupo de patología adrenal de la Sociedad Española de Endocrinología y Nutrición
Marta Araujo-Castro, Marta Iturregui Guevara, María Calatayud Gutiérrez, Paola Parra Ramírez, Paola Gracia Gimeno, Felicia Alexandra Hanzu, Cristina Lamas Oliveira
Endocrinología, Diabetes y Nutrición.2020; 67(6): 408. CrossRef
Practical guide on the initial evaluation, follow-up, and treatment of adrenal incidentalomas. Adrenal Diseases Group of the Spanish Society of Endocrinology and Nutrition
Marta Araujo-Castro, Marta Iturregui Guevara, María Calatayud Gutiérrez, Paola Parra Ramírez, Paola Gracia Gimeno, Felicia Alexandra Hanzu, Cristina Lamas Oliveira
Endocrinología, Diabetes y Nutrición (English ed.).2020; 67(6): 408. CrossRef
Endocrine Causes of Hypertension
Taniya de Silva, Gina Cosentino, Suneeta Ganji, Alejandra Riera-Gonzalez, Daniel S. Hsia
Current Hypertension Reports.2020;[Epub] CrossRef
Adrenocortical carcinoma: presentation and outcome of a contemporary patient series
Iiro Kostiainen, Liisa Hakaste, Pekka Kejo, Helka Parviainen, Tiina Laine, Eliisa Löyttyniemi, Mirkka Pennanen, Johanna Arola, Caj Haglund, Ilkka Heiskanen, Camilla Schalin-Jäntti
Endocrine.2019; 65(1): 166. CrossRef
CT Characteristics of Pheochromocytoma: Relevance for the Evaluation of Adrenal Incidentaloma
Letizia Canu, Janna A W Van Hemert, Michiel N Kerstens, Robert P Hartman, Aakanksha Khanna, Ivana Kraljevic, Darko Kastelan, Corin Badiu, Urszula Ambroziak, Antoine Tabarin, Magalie Haissaguerre, Edward Buitenwerf, Anneke Visser, Massimo Mannelli, Wiebke
The Journal of Clinical Endocrinology & Metabolism.2019; 104(2): 312. CrossRef
The Evaluation of Incidentally Discovered Adrenal Masses
Anand Vaidya, Amir Hamrahian, Irina Bancos, Maria Fleseriu, Hans K. Ghayee
Endocrine Practice.2019; 25(2): 178. CrossRef
Evaluation of quantitative parameters for distinguishing pheochromocytoma from other adrenal tumors
Youichi Ohno, Masakatsu Sone, Daisuke Taura, Toshinari Yamasaki, Katsutoshi Kojima, Kyoko Honda-Kohmo, Yorihide Fukuda, Koji Matsuo, Toshihito Fujii, Akihiro Yasoda, Osamu Ogawa, Nobuya Inagaki
Hypertension Research.2018; 41(3): 165. CrossRef
Long term follow-up of non functional adrenal incidentalomas in size: a single center experience
Güven Barış Cansu, Bengür Taşkıran, Eylem Bahadır
Ortadoğu Tıp Dergisi.2018; 10(4): 506. CrossRef
Unenhanced CT imaging is highly sensitive to exclude pheochromocytoma: a multicenter study
Edward Buitenwerf, Tijmen Korteweg, Anneke Visser, Charlotte M S C Haag, Richard A Feelders, Henri J L M Timmers, Letizia Canu, Harm R Haak, Peter H L T Bisschop, Elisabeth M W Eekhoff, Eleonora P M Corssmit, Nanda C Krak, Elise Rasenberg, Janneke van den
European Journal of Endocrinology.2018; 178(5): 431. CrossRef
The impact of an adrenal incidentaloma algorithm on the evaluation of adrenal nodules
Leslie S. Eldeiry, Marina M. Alfisher, Catherine F. Callahan, Nancy N. Hanna, Jeffrey R. Garber
Journal of Clinical & Translational Endocrinology.2018; 13: 39. CrossRef
Adrenal incidentaloma: differential diagnosis and management strategies
Valentina Morelli, Serena Palmieri
Minerva Endocrinologica.2018;[Epub] CrossRef
Adrenal Imaging
Mishal Mendiratta-Lala, Anca Avram, Adina F. Turcu, N. Reed Dunnick
Endocrinology and Metabolism Clinics of North America.2017; 46(3): 741. CrossRef
Update on the risks of benign adrenocortical incidentalomas
Guido Di Dalmazi
Current Opinion in Endocrinology, Diabetes & Obesity.2017; 24(3): 193. CrossRef
Management Scheme for Adrenal Incidentalomas: Who Gets What?
Glenda G. Callender, Robert Udelsman
Current Surgery Reports.2016;[Epub] CrossRef
Management of adrenal incidentalomas: European Society of Endocrinology Clinical Practice Guideline in collaboration with the European Network for the Study of Adrenal Tumors
Martin Fassnacht, Wiebke Arlt, Irina Bancos, Henning Dralle, John Newell-Price, Anju Sahdev, Antoine Tabarin, Massimo Terzolo, Stylianos Tsagarakis, Olaf M Dekkers
European Journal of Endocrinology.2016; 175(2): G1. CrossRef

First
Prev
Page of 1
Next
Last

Search